Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/heterogeneity-in-suspected-non-alzheimer-disease-pathophysiology-among-0go0V0sgVE
References (38)
-
R. Amariglio, E. Mormino, Alison Pietras, G. Marshall, P. Vannini, Keith Johnson, R. Sperling, D. Rentz (2015)
Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderlyNeurology, 85
-
G. Chételat (2013)
Alzheimer disease: Aβ-independent processes—rethinking preclinical ADNature Reviews Neurology, 9
-
M. Folstein, M. Folstein, S. Folstein, S. Folstein, P. McHugh, P. McHugh (1975)
“Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 12
-
B. Fischl, D. Salat, Evelina Busa, M. Albert, M. Dieterich, C. Haselgrove, A. Kouwe, R. Killiany, D. Kennedy, Shuna Klaveness, A. Montillo, N. Makris, B. Rosen, A. Dale (2002)
Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human BrainNeuron, 33
-
D. Knopman, C. Jack, H. Wiste, S. Weigand, P. Vemuri, V. Lowe, K. Kantarci, J. Gunter, M. Senjem, M. Mielke, R. Roberts, B. Boeve, R. Petersen (2013)
Brain injury biomarkers are not dependent on β‐amyloid in normal elderlyAnnals of Neurology, 73
-
S. Landau, D. Harvey, Cindee Madison, R. Koeppe, E. Reiman, N. Foster, M. Weiner, W. Jagust (2011)
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCINeurobiology of Aging, 32
-
J. Crary, J. Trojanowski, J. Schneider, J. Abisambra, E. Abner, I. Alafuzoff, S. Arnold, J. Attems, T. Beach, E. Bigio, N. Cairns, D. Dickson, M. Gearing, L. Grinberg, P. Hof, B. Hyman, K. Jellinger, G. Jicha, G. Kovacs, D. Knopman, J. Kofler, W. Kukull, I. Mackenzie, E. Masliah, A. Mckee, T. Montine, M. Murray, J. Neltner, I. Santa-María, W. Seeley, A. Serrano‐Pozo, M. Shelanski, T. Stein, M. Takao, D. Thal, J. Toledo, J. Troncoso, J. Vonsattel, C. White, T. Wisniewski, R. Woltjer, M. Yamada, P. Nelson (2014)
Primary age-related tauopathy (PART): a common pathology associated with human agingActa Neuropathologica, 128
-
C. Jack, D. Knopman, G. Chételat, Dennis Dickson, A. Fagan, G. Frisoni, W. Jagust, E. Mormino, R. Petersen, R. Sperling, W. Flier, V. Villemagne, P. Visser, S. Vos (2016)
Suspected non-Alzheimer disease pathophysiology — concept and controversyNature Reviews Neurology, 12
-
D. Knopman, C. Jack, H. Wiste, S. Weigand, P. Vemuri, V. Lowe, K. Kantarci, J. Gunter, M. Senjem, R. Ivnik, R. Roberts, B. Boeve, R. Petersen (2012)
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer diseaseNeurology, 78
-
Keith Johnson, A. Schultz, R. Betensky, J. Becker, J. Sepulcre, D. Rentz, E. Mormino, J. Chhatwal, R. Amariglio, K. Papp, G. Marshall, M. Albers, S. Mauro, L. Pepin, Jonathan Alverio, Kelly Judge, Marlie Philiossaint, T. Shoup, Daniel Yokell, B. Dickerson, T. Gómez-Isla, B. Hyman, N. Vasdev, R. Sperling (2016)
Tau positron emission tomographic imaging in aging and early Alzheimer diseaseAnnals of Neurology, 79
-
E. Mormino, R. Betensky, T. Hedden, A. Schultz, R. Amariglio, D. Rentz, Keith Johnson, R. Sperling (2014)
Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals.JAMA neurology, 71 11
-
D. Knopman, C. Jack, H. Wiste, Emily Lundt, S. Weigand, P. Vemuri, V. Lowe, K. Kantarci, J. Gunter, M. Senjem, M. Mielke, R. Roberts, B. Boeve, R. Petersen (2014)
18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal personsNeurobiology of Aging, 35
-
John Hardy, D. Selkoe (2002)
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 297
-
R. Dawe, D. Bennett, J. Schneider, K. Arfanakis (2011)
Neuropathologic Correlates of Hippocampal Atrophy in the Elderly: A Clinical, Pathologic, Postmortem MRI StudyPLoS ONE, 6
-
E. Mormino, R. Betensky, T. Hedden, A. Schultz, Andrew Ward, W. Huijbers, D. Rentz, Keith Johnson, R. Sperling (2014)
Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer diseaseNeurology, 82
-
David Chien, A. Szardenings, S. Bahri, J. Walsh, Fanrong Mu, Chunfang Xia, W. Shankle, A. Lerner, M. Su, Arkadij Elizarov, H. Kolb (2014)
Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.Journal of Alzheimer's disease : JAD, 38 1
-
C. Duyckaerts, H. Braak, J. Brion, L. Buée, K. Tredici, M. Goedert, G. Halliday, M. Neumann, M. Spillantini, M. Tolnay, T. Uchihara (2015)
PART is part of Alzheimer diseaseActa Neuropathologica, 129
-
N. Raz, Faith Gunning-Dixon, D. Head, K. Rodrigue, Adrienne Williamson, J. Acker (2004)
Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: replicability of regional differences in volumeNeurobiology of Aging, 25
-
D. Thal, T. Beach, Michelle Zanette, K. Heurling, A. Chakrabarty, Azzam Ismail, Adrian Smith, C. Buckley (2015)
[18F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-β pathologyAlzheimer's & Dementia, 11
-
J. Morris (1993)
The Clinical Dementia Rating (CDR)Neurology, 43
-
H. Braak, E. Braak (1997)
Frequency of Stages of Alzheimer-Related Lesions in Different Age CategoriesNeurobiology of Aging, 18
-
R. Sperling, P. Aisen, L. Beckett, D. Bennett, S. Craft, A. Fagan, T. Iwatsubo, C. Jack, J. Kaye, T. Montine, Denise Park, E. Reiman, C. Rowe, E. Siemers, Y. Stern, K. Yaffe, M. Carrillo, B. Thies, M. Morrison‐Bogorad, M. Wagster, C. Phelps (2011)
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 7
-
M. Donohue, R. Sperling, D. Salmon, D. Rentz, R. Raman, Ronald Thomas, M. Weiner, P. Aisen (2014)
The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.JAMA neurology, 71 8
-
C. Jack, D. Knopman, W. Jagust, R. Petersen, M. Weiner, P. Aisen, L. Shaw, P. Vemuri, H. Wiste, S. Weigand, T. Lesnick, V. Pankratz, M. Donohue, J. Trojanowski (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkersThe Lancet Neurology, 12
-
C. Jack, H. Wiste, S. Weigand, D. Knopman, V. Lowe, P. Vemuri, M. Mielke, David Jones, M. Senjem, J. Gunter, Brian Gregg, V. Pankratz, R. Petersen (2013)
Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivityNeurology, 81
-
S. Vos, C. Xiong, P. Visser, Mateusz Jasielec, J. Hassenstab, E. Grant, N. Cairns, J. Morris, D. Holtzman, A. Fagan (2013)
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort studyThe Lancet Neurology, 12
-
M. Wirth, S. Villeneuve, C. Haase, Cindee Madison, Hwamee Oh, S. Landau, G. Rabinovici, W. Jagust (2013)
Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.JAMA neurology, 70 12
-
C. Rowe, K. Ellis, M. Rimajova, P. Bourgeat, K. Pike, Gareth Jones, J. Fripp, H. Tochon-Danguy, L. Morandeau, G. O'Keefe, R. Price, P. Raniga, P. Robins, Oscar Acosta, N. Lenzo, C. Szoeke, O. Salvado, R. Head, Ralph Martins, C. Masters, D. Ames, V. Villemagne (2010)
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of agingNeurobiology of Aging, 31
-
K. Josephs, J. Whitwell, Nirubol Tosakulwong, S. Weigand, M. Murray, Amanda Liesinger, L. Petrucelli, M. Senjem, R. Ivnik, J. Parisi, R. Petersen, D. Dickson (2015)
TAR DNA‐binding protein 43 and pathological subtype of Alzheimer's disease impact clinical featuresAnnals of Neurology, 78
-
C. Jack (2014)
PART and SNAPActa Neuropathologica, 128
-
K. Papp, R. Amariglio, E. Mormino, T. Hedden, Maria Dekhytar, Keith Johnson, R. Sperling, D. Rentz (2015)
Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer’s diseaseNeuropsychologia, 73
-
C. Jack, D. Dickson, J. Parisi, Yc Xu, Rh Cha, P. O'brien, Sd Edland, G.E. Smith, B. Boeve, Eg Tangalos, E. Kokmen, R. Petersen (2002)
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementiaNeurology, 58
-
B. Dickerson, A. Bakkour, D. Salat, E. Feczko, J. Pacheco, D. Greve, F. Grodstein, C. Wright, C. Wright, D. Blacker, H. Rosas, R. Sperling, A. Atri, J. Growdon, B. Hyman, J. Morris, B. Fischl, B. Fischl, R. Buckner, R. Buckner (2008)
The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive IndividualsCerebral Cortex (New York, NY), 19
-
C. Reynolds, J. Powel (1988)
Wechsler memory scale-revisedArchives of Clinical Neuropsychology, 3
-
K. Jellinger, I. Alafuzoff, J. Attems, T. Beach, N. Cairns, J. Crary, D. Dickson, P. Hof, B. Hyman, C. Jack, G. Jicha, D. Knopman, G. Kovacs, I. Mackenzie, E. Masliah, T. Montine, P. Nelson, F. Schmitt, J. Schneider, A. Serrano‐Pozo, D. Thal, J. Toledo, J. Trojanowski, J. Troncoso, J. Vonsattel, T. Wisniewski (2015)
PART, a distinct tauopathy, different from classical sporadic Alzheimer diseaseActa Neuropathologica, 129
-
C. Jack, D. Knopman, S. Weigand, H. Wiste, P. Vemuri, V. Lowe, K. Kantarci, J. Gunter, M. Senjem, R. Ivnik, R. Roberts, W. Rocca, B. Boeve, R. Petersen (2012)
An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer diseaseAnnals of Neurology, 71
-
P. Nelson, I. Alafuzoff, E. Bigio, C. Bouras, H. Braak, N. Cairns, Rudolph Castellani, B. Crain, P. Davies, K. Tredici, C. Duyckaerts, M. Frosch, V. Haroutunian, P. Hof, C. Hulette, B. Hyman, T. Iwatsubo, K. Jellinger, G. Jicha, E. Kövari, W. Kukull, J. Leverenz, S. Love, I. Mackenzie, D. Mann, E. Masliah, A. Mckee, T. Montine, J. Morris, J. Schneider, J. Sonnen, D. Thal, J. Trojanowski, J. Troncoso, T. Wisniewski, R. Woltjer, T. Beach (2012)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the LiteratureJournal of Neuropathology & Experimental Neurology, 71
-
JC Morris (1993)
The Clinical Dementia Rating (CDR): current version and scoring rules, 43
- Publisher
- American Medical Association
- Copyright
- Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
- ISSN
- 2168-6149
- eISSN
- 2168-6157
- DOI
- 10.1001/jamaneurol.2016.2237
- pmid
- 27548655
- Publisher site
- See Article on Publisher Site
Abstract
This cohort study assesses PET-measured tau deposition and cognitive decline over 5 years in Harvard Aging Brain study participants who were beta-amyloid-negative with neurodegeneration at baseline.
Journal
JAMA Neurology – American Medical Association
Published: Oct 22, 2016